Sage Journals: Discover world-class research

Abstract

Aims:

Downregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) contributes to doxorubicin (DOX)-induced myocardial oxidative stress, and inhibition of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) increased Nrf2 protein level in rat heart suffering ischemia/reperfusion, indicating a connection between MALT1 and Nrf2. This study aims to explore the role of MALT1 in DOX-induced myocardial oxidative stress and the underlying mechanisms.

Results:

The mice received a single injection of DOX (15 mg/kg, i.p.) to induce myocardial oxidative stress, evidenced by increases in the levels of reactive oxidative species as well as decreases in the activities of antioxidative enzymes, concomitant with a downregulation of Nrf2; these phenomena were reversed by MALT1 inhibitor. Similar phenomena were observed in DOX-induced oxidative stress in cardiomyocytes. Mechanistically, knockdown or inhibition of MALT1 notably attenuated the interaction between Nrf2 and MALT1 and decreased the k48-linked ubiquitination of Nrf2. Furthermore, inhibition or knockdown of calcium/calmodulin-dependent protein kinase II (CaMKII-δ) reduced the phosphorylation of caspase recruitment domain-containing protein 11 (CARD11), subsequently disrupted the assembly of CARD11, B cell lymphoma 10 (BCL10), and MALT1 (CBM) complex, and reduced the MALT1-dependent k48-linked ubiquitination of Nrf2 in DOX-treated mice or cardiomyocytes.

Innovation and Conclusion:

The E3 ubiquitin ligase function of MALT1 accounts for the downregulation of Nrf2 and aggravation of myocardial oxidative stress in DOX-treated mice, and CaMKII-δ-dependent phosphorylation of CARD11 triggered the assembly of CBM complex and the subsequent activation of MALT1. Antioxid. Redox Signal. 42, 115–132.

Get full access to this article

View all access options for this article.

References

Carvalho

, Burgeiro

, Garcia

, et al. Doxorubicin-induced cardiotoxicity: From bioenergetic failure and cell death to cardiomyopathy. Med Res Rev, 2014; 34(1):106–135; doi: 10.1002/med.21280

Chatterjee

, Zhang

, Honbo

, et al. Doxorubicin cardiomyopathy. Cardiology, 2010; 115(2):155–162; doi: 10.1159/000265166

Cheng

, Wu

, Nie

, et al. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway. Phytomedicine, 2022; 106:154407; doi: 10.1016/j.phymed.2022.154407

Coornaert

, Baens

, Heyninck

, et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappa B inhibitor A20. Nat Immunol, 2008; 9(3):263–271; doi: 10.1038/ni1561

Eggler

, Liu

, Pezzuto

, et al. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci U S A, 2005; 102(29):10070–10075; doi: 10.1073/pnas.0502402102

Eggler

, Small

, Hannink

, et al. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. Biochem J, 2009; 422(1):171–180; doi: 10.1042/BJ20090471

Fontan

, Yang

, Kabaleeswaran

, et al. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo . Cancer Cell, 2012; 22(6):812–824; doi: 10.1016/j.ccr.2012.11.003

Gehring

, Seeholzer

, Krappmann

. BCL10—Bridging CARDs to immune activation. Front Immunol, 2018; 9:1539; doi: 10.3389/fimmu.2018.01539

Hailfinger

, Nogai

, Pelzer

, et al. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc Natl Acad Sci U S A, 2011; 108(35):14596–14601; doi: 10.1073/pnas.1105020108

10.

, Xi

, Fang

, et al. Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis. Free Radic Biol Med, 2023; 206:13–21; doi: 10.1016/j.freeradbiomed.2023.06.025

11.

Hortobagyi

. Anthracyclines in the treatment of cancer. An overview. Drugs, 1997; 54Suppl 4:1–7; doi: 10.2165/00003495-199700544-00003

12.

, Liu

, Yang

, et al. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway. Food Funct, 2023; 14(8):3849–3862; doi: 10.1039/d2fo03904d

13.

Ishiguro

, Ando

, Goto

, et al. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II. Mol Immunol, 2007; 44(8):2095–2100; doi: 10.1016/j.molimm.2006.09.012

14.

Itoh

, Wakabayashi

, Katoh

, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev, 1999; 13(1):76–86; doi: 10.1101/gad.13.1.76

15.

Jeltsch

, Hu

, Brenner

, et al. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation. Nat Immunol, 2014; 15(11):1079–1089; doi: 10.1038/ni.3008

16.

Jiang

, Chen

, Tian

, et al. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway. Phytomedicine, 2022; 106:154439; doi: 10.1016/j.phymed.2022.154439

17.

Jiang

, Yang

, Duan

, et al. Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway. Eur J Pharmacol, 2023; 950:175774; doi: 10.1016/j.ejphar.2023.175774

18.

Klein

, Fung

, Renner

, et al. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-kappaB signalling. Nat Commun, 2015; 6:8777; doi: 10.1038/ncomms9777

19.

Mayer

, Mohlig

, Idlibe

, et al. Novel and uncommon isoforms of the calcium sensing enzyme calcium/calmodulin dependent protein kinase II in heart tissue. Basic Res Cardiol, 1995; 90(5):372–379; doi: 10.1007/BF00788498

20.

Oeckinghaus

, Wegener

, Welteke

, et al. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. Embo J, 2007; 26(22):4634–4645; doi: 10.1038/sj.emboj.7601897

21.

Oruganti

, Edin

, Grundstrom

, et al. CaMKII targets Bcl10 in T-cell receptor induced activation of NF-kappaB. Mol Immunol, 2011; 48(12–13):1448–1460; doi: 10.1016/j.molimm.2011.03.020

22.

Rebeaud

, Hailfinger

, Posevitz-Fejfar

, et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol, 2008; 9(3):272–281; doi: 10.1038/ni1568

23.

Roberts

, Rainbow

, Sharma

. Mitigation of cardiovascular disease and toxicity through NRF2 signalling. Int J Mol Sci, 2023; 24(7); doi: 10.3390/ijms24076723

24.

Singal

, Iliskovic

. Doxorubicin-induced cardiomyopathy. N Engl J Med, 1998; 339(13):900–905; doi: 10.1056/NEJM199809243391307

25.

Staal

, Driege

, Bekaert

, et al. T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. Embo J, 2011; 30(9):1742–1752; doi: 10.1038/emboj.2011.85

26.

Swain

, Whaley

, Ewer

. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer, 2003; 97(11):2869–2879; doi: 10.1002/cncr.11407

27.

Tonelli

, Chio

IIC

, Tuveson

. Transcriptional regulation by Nrf2. Antioxid Redox Signal, 2018; 29(17):1727–1745; doi: 10.1089/ars.2017.7342

28.

Wallace

, Sardao

, Oliveira

. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res, 2020; 126(7):926–941; doi: 10.1161/CIRCRESAHA.119.314681

29.

Yang

, Liu

, Fang

, et al. Novel pterostilbene derivatives ameliorate heart failure by reducing oxidative stress and inflammation through regulating Nrf2/NF-kappaB signaling pathway. Eur J Med Chem, 2023; 258:115602; doi: 10.1016/j.ejmech.2023.115602

30.

Yao

, Li

, Zhang

, et al. Targeting CaMKII-delta9 ameliorates cardiac Ischemia/Reperfusion injury by inhibiting myocardial inflammation. Circ Res, 2022; 130(6):887–903; doi: 10.1161/CIRCRESAHA.121.319478

31.

Young

, Ozols

, Myers

. The anthracycline antineoplastic drugs. N Engl J Med, 1981; 305(3):139–153; doi: 10.1056/NEJM198107163050305

32.

, Wang

, Kong

, et al. Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products. Phytomedicine, 2018; 40:125–139; doi: 10.1016/j.phymed.2018.01.009

33.

Zhang

, Liang

, Wang

, et al. Novel CaMKII-delta inhibitor Hesperadin exerts dual functions to ameliorate cardiac Ischemia/Reperfusion injury and inhibit tumor growth. Circulation, 2022; 145(15):1154–1168; doi: 10.1161/CIRCULATIONAHA.121.055920

34.

Zhang

, Lo

, Cross

, et al. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol, 2004; 24(24):10941–10953; doi: 10.1128/MCB.24.24.10941-10953.2004

35.

Zhang

, Zhang

, Cui

, et al. CaMKII is a RIP3 substrate mediating ischemia—and oxidative stress-induced myocardial necroptosis. Nat Med, 2016; 22(2):175–182; doi: 10.1038/nm.4017

36.

Zhou

, Hao

, Zhong

, et al. Fecal microbiota transplantation in mice exerts a protective effect against doxorubicin-induced cardiac toxicity by regulating Nrf2-Mediated cardiac mitochondrial fission and fusion. Antioxid Redox Signal, 2023; doi: 10.1089/ars.2023.0355

37.

Zhou

, Wertz

, O’Rourke

, et al. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature, 2004; 427(6970):167–171; doi: 10.1038/nature02273

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

12.04 MB

CARD11-BCL10-MALT1 Complex-Dependent MALT1 Activation Facilitates Myocardial Oxidative Stress in Doxorubicin-Treated Mice via Enhancing k48-Linked Ubiquitination of Nrf2

Abstract

Aims:

Results:

Innovation and Conclusion:

Get full access to this article

References

Supplementary Material